In conjunction with the Private Placement, the Company has resolved to divest 1,616,498 shares in AecorBio for approx. USD 5 million at a price per share of USD 3.0931, corresponding to a valuation ...
Revenue-- $126.5 million total revenue for Q3 2025, representing 16% sequential growth and 56% year-over-year revenue growth. Segment Revenue-- Infrastructure revenue was approximately $40 million for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback